BACKGROUND AND PURPOSE: Previous studies have demonstrated limited benefit with endovascular procedures such as stent placement in octogenarians. We evaluated the safety and effectiveness of intra-arterial recanalization techniques to treat ischemic stroke in patients 80 years or older presenting within 6 hours of symptom onset. MATERIALS AND METHODS: We pooled the data from 4 prospective studies by evaluating intra-arterial recanalization techniques for treatment of ischemic stroke. Clinical and radiologic evaluations were performed before treatment and at 24 hours, 7 to 10 days, and 1 to 3 months after treatment. We performed multivariate analyses to evaluate the effect of ages 80 years and older on angiographic recanalization, favorable outcome (modified Rankin scale of 0-2), and mortality rate at 1 to 3 months. RESULTS: A total of 101 patients were treated in the 4 protocols. Of these, 24 were 80 years or older. There was no significant difference between the 2 age groups in sex, initial stroke severity, time to treatment, site of vascular occlusion, and rate of symptomatic and asymptomatic intracranial hemorrhage (ICH). In logistic regression analysis, age 80 years or older was associated with a lower likelihood of a favorable outcome (odds ratio [OR], 0.40; 95% confidence interval [CI], 0.13-1.2; P = .11) and recanalization (OR, 0.36; 95% CI, 0.12-1.1; P = .07) and with higher mortality rate (OR, 3.17; 95% CI, 1.05-9.55; P = .04) after adjusting for study protocol. After adjusting for recanalization in addition to study protocol, the older age group still had a lower likelihood of favorable outcomes (OR, 0.34; 95% CI, 0.1-1.1; P = .07) and higher mortality rates (OR, 3.62; 95% CI, 1.15-11.36; P = .027). CONCLUSIONS: Our study demonstrates that patients 80 years and older are at higher risk for poor outcome at 1 to 3 months following intra-arterial recanalization techniques. This relationship is independent of recanalization rate and symptomatic ICH supporting the role of other mechanisms.
BACKGROUND AND PURPOSE: Previous studies have demonstrated limited benefit with endovascular procedures such as stent placement in octogenarians. We evaluated the safety and effectiveness of intra-arterial recanalization techniques to treat ischemic stroke in patients 80 years or older presenting within 6 hours of symptom onset. MATERIALS AND METHODS: We pooled the data from 4 prospective studies by evaluating intra-arterial recanalization techniques for treatment of ischemic stroke. Clinical and radiologic evaluations were performed before treatment and at 24 hours, 7 to 10 days, and 1 to 3 months after treatment. We performed multivariate analyses to evaluate the effect of ages 80 years and older on angiographic recanalization, favorable outcome (modified Rankin scale of 0-2), and mortality rate at 1 to 3 months. RESULTS: A total of 101 patients were treated in the 4 protocols. Of these, 24 were 80 years or older. There was no significant difference between the 2 age groups in sex, initial stroke severity, time to treatment, site of vascular occlusion, and rate of symptomatic and asymptomatic intracranial hemorrhage (ICH). In logistic regression analysis, age 80 years or older was associated with a lower likelihood of a favorable outcome (odds ratio [OR], 0.40; 95% confidence interval [CI], 0.13-1.2; P = .11) and recanalization (OR, 0.36; 95% CI, 0.12-1.1; P = .07) and with higher mortality rate (OR, 3.17; 95% CI, 1.05-9.55; P = .04) after adjusting for study protocol. After adjusting for recanalization in addition to study protocol, the older age group still had a lower likelihood of favorable outcomes (OR, 0.34; 95% CI, 0.1-1.1; P = .07) and higher mortality rates (OR, 3.62; 95% CI, 1.15-11.36; P = .027). CONCLUSIONS: Our study demonstrates that patients 80 years and older are at higher risk for poor outcome at 1 to 3 months following intra-arterial recanalization techniques. This relationship is independent of recanalization rate and symptomatic ICH supporting the role of other mechanisms.
Authors: A Zangerle; S Kiechl; M Spiegel; M Furtner; M Knoflach; P Werner; A Mair; G Wille; C Schmidauer; K Gautsch; T Gotwald; S Felber; W Poewe; J Willeit Journal: Neurology Date: 2007-01-02 Impact factor: 9.910
Authors: W B Batchelor; K J Anstrom; L H Muhlbaier; R Grosswald; W S Weintraub; W W O'Neill; E D Peterson Journal: J Am Coll Cardiol Date: 2000-09 Impact factor: 24.094
Authors: Robert W Hobson; Virginia J Howard; Gary S Roubin; Thomas G Brott; Robert D Ferguson; Jeffrey J Popma; Darlene L Graham; George Howard Journal: J Vasc Surg Date: 2004-12 Impact factor: 4.268
Authors: Yousef Mohammad; Andrew R Xavier; Greg Christoforidis; Eric Bourekas; Andrew Slivka Journal: J Neuroimaging Date: 2004-07 Impact factor: 2.486
Authors: H Urbach; A Hartmann; C Pohl; H Omran; K Wilhelm; S Flacke; H H Schild; T Klockgether Journal: Neuroradiology Date: 2002-06-29 Impact factor: 2.804
Authors: Ronen R Leker; Carlos Molina; Kevin Cockroft; David S Liebeskind; Mauricio Concha; Ashfaq Shuaib; Peter Paul De Deyn; W Scott Burgin; Rishi Gupta; William Dillon; Hans-Christoph Diener Journal: Cerebrovasc Dis Date: 2012-10-11 Impact factor: 2.762
Authors: H M Hussein; A L Georgiadis; G Vazquez; J T Miley; M Z Memon; Y M Mohammad; G A Christoforidis; N Tariq; A I Qureshi Journal: AJNR Am J Neuroradiol Date: 2010-01-14 Impact factor: 3.825
Authors: Amrou Sarraj; Karen Albright; Andrew D Barreto; Amelia K Boehme; Clark W Sitton; Jeanie Choi; Steven L Lutzker; Chung-Huan J Sun; Wafi Bibars; Claude B Nguyen; Osman Mir; Farhaan Vahidy; Tzu-Ching Wu; George A Lopez; Nicole R Gonzales; Randall Edgell; Sheryl Martin-Schild; Hen Hallevi; Peng Roc Chen; Mark Dannenbaum; Jeffrey L Saver; David S Liebeskind; Raul G Nogueira; Rishi Gupta; James C Grotta; Sean I Savitz Journal: Stroke Date: 2013-08-08 Impact factor: 7.914
Authors: Rudolf Luedi; Kety Hsieh; Agnieszka Slezak; Marwan El-Koussy; Urs Fischer; Mirjam R Heldner; Julia Meisterernst; Marie-Luise Mono; Christoph Zubler; Pasquale Mordasini; Christoph Ozdoba; Heinrich P Mattle; Gerhard Schroth; Jan Gralla; Marcel Arnold; Simon Jung Journal: J Neurol Date: 2014-06-11 Impact factor: 4.849